DEUTSCHE BANK AG\ - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$398,000
-56.5%
42,476
+14.0%
0.00%
Q2 2023$913,914
-65.6%
37,257
-67.4%
0.00%
-100.0%
Q1 2023$2,657,597
-26.6%
114,207
-20.2%
0.00%
-50.0%
Q4 2022$3,621,532
+377.1%
143,087
+263.2%
0.00%
Q3 2022$759,000
-31.1%
39,395
-8.9%
0.00%
-100.0%
Q2 2022$1,101,000
-3.8%
43,240
-2.8%
0.00%0.0%
Q1 2022$1,144,000
-43.3%
44,478
-7.8%
0.00%0.0%
Q4 2021$2,019,000
-7.0%
48,226
-3.4%
0.00%0.0%
Q3 2021$2,171,000
-2.6%
49,902
+5.9%
0.00%0.0%
Q2 2021$2,228,000
+3.9%
47,140
+12.7%
0.00%0.0%
Q1 2021$2,145,000
+75.1%
41,830
-8.5%
0.00%0.0%
Q4 2020$1,225,000
+15.9%
45,728
+48.5%
0.00%0.0%
Q3 2020$1,057,000
+10.3%
30,803
+31.7%
0.00%0.0%
Q2 2020$958,000
+1014.0%
23,393
+839.1%
0.00%
Q1 2020$86,000
+152.9%
2,491
-11.4%
0.00%
Q4 2019$34,0002,8110.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders